Clinical Trial: A phase II randomised controlled trial comparing carbon-ion radiotherapy (3 GyE in fractions) with concurrent chemoradiotherapy for the treatment of locally advanced recurrent nasopharyngeal carcinoma (China)

China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A phase II randomised controlled trial comparing carbon-ion radiotherapy (3 GyE in fractions) with concurrent chemoradiotherapy for the treatment of locally advanced recurrent nasopharyngeal carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133760

Registration Time: 2026/10/07

Type: Interventional study

Primary Sponsor: Shanghai Proton and Heavy Ion Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332773

Published by HT Digital Content Services with permission from Health Daily Digest....